Supraclavicular Approach to the Subclavian Vein as an Alternative Venous Access Site for ECMO Cannulae? A Retrospective Comparison

ASAIO Journal ◽  
2017 ◽  
Vol 63 (5) ◽  
pp. 679-683 ◽  
Author(s):  
Andja Bojic ◽  
Irene Steiner ◽  
Jutta Gamper ◽  
Peter Schellongowski ◽  
Wolfgang Lamm ◽  
...  
Keyword(s):  
Subclavian Vein ◽  
Venous Access ◽  
Access Site ◽  
Supraclavicular Approach ◽  
Retrospective Comparison ◽  
Venous Access Site

scholarly journals Reduced Complications of Supraclavicular Approach in Simulated Central Venous Access: Applicability to Military Medicine

2019 ◽  
Vol 184 (Supplement_1) ◽  
pp. 329-334
Author(s):  
Joshua Sappenfield ◽  
Sasha Grek ◽  
Lou Ann Cooper ◽  
David E Lizdas ◽  
Samsun Lampotang
Keyword(s):  
Subclavian Vein ◽  
Mixed Reality ◽  
Central Venous Access ◽  
Military Medicine ◽  
Venous Access ◽  
Central Venous ◽  
Supraclavicular Approach ◽  
Anesthesia Providers ◽  
Alternative Approach ◽  
Simulation Based

Abstract In a study with 76 anesthesia providers on a mixed reality simulator, central venous access via the supraclavicular approach to the subclavian vein, without ultrasonography required less attempts compared to the infraclavicular approach. Participants had shorter times to venous access and larger improvements in confidence. Results from this simulation-based study indicate that the supraclavicular approach may deserve consideration as an alternative approach for central venous access in deployed military environments. The use of ultrasonography during the supraclavicular approach to the subclavian vein is also described which may improve its safety profile. This technique could be more appropriate in scenarios when central venous access is preferred over intraosseous access for patients being transported to another location for further care.

scholarly journals Ultrasound-guided central venous access: which probe is preferred for viewing the subclavian vein using a supraclavicular approach?

2016 ◽  
Vol 34 (9) ◽  
pp. 1761-1764 ◽  
Author(s):  
Shadi Lahham ◽  
Sean P. Wilson ◽  
Mohammad Subeh ◽  
Michael Butterfield ◽  
Abdelhafez R. Albakri ◽  
...  
Keyword(s):  
Subclavian Vein ◽  
Central Venous Access ◽  
Venous Access ◽  
Ultrasound Guided ◽  
Central Venous ◽  
Supraclavicular Approach

The effect of nitroglycerin ointment on great saphenous vein targeted venous access site diameter with endovenous laser treatment

2008 ◽  
Vol 23 (5) ◽  
pp. 222-226 ◽  
Author(s):  
R S Hogue ◽  
M W Schul ◽  
C F Dando ◽  
B E Erdman
Keyword(s):  
Laser Treatment ◽  
Saphenous Vein ◽  
Great Saphenous Vein ◽  
Venous Access ◽  
Percentage Change ◽  
Access Site ◽  
Nitroglycerin Ointment ◽  
Vein Diameter ◽  
Endovenous Laser Treatment ◽  
Venous Access Site

Objectives To assess the effect of topically applied nitroglycerin (NTG) ointment (2%) on preoperative targeted venous access site great saphenous vein (GSV) diameter in patients undergoing endovenous laser treatment (ELT). Methods In this double-blinded randomized study design, 75 patients received either (A) treadmill ambulation only, (B) topically applied NTG ointment only, or (C) topically applied NTG ointment + treadmill ambulation. Targeted venous access vein diameters were measured before therapeutic intervention and then repeated after approximately 30 min following pretreatment intervention. Presence of venospasm and the number of ultrasound-guided venous access attempts during each ELT procedure were assessed during the study. Results The mean pretreatment vein diameter was 2.6 mm (range 0.9–4.9 mm). The post-treatment percentage change in vein diameter for group A (treadmill ambulation only) was +2.7% ( P = 0.403), whereas group B (NTG only) and group C (NTG + treadmill ambulation) demonstrated significant venodilatation of +69.0% ( P < 0.0001) and +51.7% ( P < 0.0001), respectively. Statistical analysis of variances and multivariate linear regression model revealed topically applied NTG ointment and ‘C’ classification of clinical, aetiological, anatomical and pathological elements (CEAP) were each significant predictors for venodilatation percentage change ( P < 0.001 and = 0.028, respectively). Conclusion Pretreatment with topically applied NTG ointment (2%) produced a statistically significant, as well as subjective clinically significant venodilatation change in the targeted venous access site diameter of patients undergoing ELT of the GSV in this study.

scholarly journals Comparison of HemoFoam® and Conventional Gauze Dressing on Hemostasis of Vascular Access Site in Hemodialysis Patients

2019 ◽  
Vol 8 ◽  
pp. 1395
Author(s):  
Davood Bizari ◽  
Hadi Khoshmohabat ◽  
Soheila Salahshour Kordestani ◽  
Rouhollah Zarepur
Keyword(s):  
Vascular Access ◽  
Venous Access ◽  
Hemodialysis Patients ◽  
Dialysis Access ◽  
Access Site ◽  
Puncture Wound ◽  
Arterial Access ◽  
Gauze Dressing ◽  
The Mean ◽  
Venous Access Site

Background: Dialysis access puncture wound bleeding after needle extraction at the end of each hemodialysis session is a very important problem. This study evaluated the effect of HemoFoam® compared to conventional gauze dressing on hemostasis of dialysis access puncture wound bleeding in hemodialysis patients. Materials and Methods: This one-group, before-after, clinical-trial was conducted on 60 hemodialysis patients selected by convenience sampling who underwent hemodialysis through arteriovenous fistula in Shahid Rahnemoon Hospital, Yazd, Iran in 2017. After reviewing the eligibility criteria, the study was performed in two separate sessions. In the first session, only HemoFoam® was used while in the second session; the only conventional dressing was used. Time of hemostasis in each puncture wound was evaluated. Data were analyzed by SPSS 22 (IBM SPSS Statistics for Windows, Armonk, NY: IBM Corp, United States) using paired T-test and Chi-square tests. Results: The mean age of the patients was 55.20±14.25 years. Hemostasis was achieved in 76.6% of cases at the arterial access site in the first two minutes in the HemoFoam® group. The mean homeostasis time in the HemoFoam® group was 2.86±1.87 min at the venous access site and 3.15±1.97 min at the arterial access site (P<0.001). The mean homeostasis time in the conventional dressing group was 10.54±6.65 min at venous access site and 12.74±9.28 min at the arterial access site, which was significantly different between the two groups (P<0.001). Conclusion: HemoFoam® is effective in reducing the time of homeostasis in the vascular access site of hemodialysis patients. Therefore, its use in hemodialysis wards is recommended for hemostasis in the dialysis access puncture wound bleeding. [GMJ.2019;8:e1395]

Subcutaneous Port Malfunction: A Retrospective Comparison Between Internal Jugular and Subclavian Vein Access

2015 ◽  
Vol 20 (4) ◽  
pp. 229-234
Author(s):  
Mahmoud Samman ◽  
Tomas Mujo ◽  
John J. Harris ◽  
Douglas M. Coldwell ◽  
Melissa Hite-Potts ◽  
...  
Keyword(s):  
Internal Jugular Vein ◽  
Subclavian Vein ◽  
Preventive Measures ◽  
Jugular Vein ◽  
Venous Access ◽  
Port Catheter ◽  
Port Placement ◽  
Access Port ◽  
Vein Access ◽  
Retrospective Comparison

Abstract Purpose: To evaluate malfunction rates of subcutaneous chest ports placed via the internal jugular and subclavian veins. Analysis and preventive measures to reduce the risk of complication between the 2 sites of venous access will be discussed. Methodology: Retrospective review of 114 patients with malfunctioning subcutaneous port-a-catheters was performed. Of those 114 patients, 77 had venous access via a subclavian approach, whereas the remaining 37 had internal jugular vein access. Port insertion placement was evaluated and analysis of the malfunction rate was performed. Results: There were 36 patients with 38 subcutaneous port malfunctions from internal jugular vein access. Thirty-four of 38 complications (89%) were not related to insertion and 4 out of 38 (11%) were related to vascular access approach. Seventy-seven patients with malfunctioning subcutaneous ports placed via the subclavian vein had a total of 127 complications. Twenty-eight of 127 complications (22%) were not related to insertion and 99 out of 127 (78%) of the complications were directly related to venous access approach. Conclusions: Subcutaneous port placement complications can be avoided by measuring the length of the port catheter under fluoroscopic guidance and positioning the tip within 2 cm of the cavoatrial junction. Also, the jugular vein should be the first site for access unless patient circumstances do not permit this approach.

Sign in / Sign up

Export Citation Format

Share Document